NCT00044447View on ClinicalTrials.gov

Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione

PHASE3CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

May 31, 2001

Study Completion Date

September 30, 2002

Conditions
Diabetes Mellitus, Non-Insulin-Dependent
Interventions
DRUG

Glimepiride

Trial Locations (1)

75230

Dallas Diabetes & Endocrine Center, Dallas

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY